Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tipetidine adjunct to methylphenidate in children with ADHD
IRCT20090117001556N108Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Methylphenidate + placebo with Methylphenidate + tipetidine (2 arms). Primary endpoint: Severity of ADHD. Started Apr 2018; status: completed.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on IRCT20090117001556N108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20090117001556N108.